Theophylline-induced protection in myoglobinuric acute renal failure: further characterization.
We have reported previously that aminophylline has an ameliorating effect on the course and severity of glycerol-induced myoglobinuric acute renal failure in rats. Since aminophylline dissociates into theophylline in biological fluids and since theophylline is an adenosine receptor antagonist, we attributed the ameliorating effects to antagonism of the hemodynamic effects of endogenous adenosine. However, theophylline blocks tubuloglomerular feedback and produces natriuresis, and either of these effects might have accounted for the beneficial effects in acute renal failure. Therefore, this study was designed to further characterize the effects of theophylline in glycerol-induced acute renal failure in rats. Aminophylline had dose-dependent beneficial effects, as judged by the peak serum creatinine during the 3 days following induction of acute renal failure, by the number of animals with peak serum creatinine greater than 1 mg/dL, and by the mortality rate. Both furosemide and theophylline block tubuloglomerular feedback and produce natriuresis, but aminophylline had protective effects, whereas furosemide actually increased mortality, compared with aminophylline, following induction of myoglobinuric acute renal failure. Therefore, aminophylline's protective effects are independent of tubuloglomerular feedback and natriuresis. These results offer further support for the hypothesis that adenosine-induced hemodynamic changes play a pathogenic role in glycerol-induced acute renal failure in rats.
D058186:Acute Kidney Injury / Q000503:physiopathology* / Q000517:prevention & control / Q000652:urine; D000628:Aminophylline / Q000494:pharmacology*; D000818:Animals; D005260:Female; D005665:Furosemide / Q000494:pharmacology*; D009212:Myoglobinuria / Q000503:physiopathology*; D009318:Natriuresis / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D012206:Rhabdomyolysis / Q000503:physiopathology*; D013806:Theophylline / Q000627:therapeutic use*
D000628:Aminophylline; D005665:Furosemide; D013806:Theophylline